ADHD Research News

New ADHD research studies referenced in this week's ADHD in the News:

  • Bschor, Tom, et al. “Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders: A Systematic Review and Meta-Analysis.” JAMA Psychiatry (May 29, 2024). DOI: 10.1001/jamapsychiatry.2024.0994.
    • Referenced in “Symptom Improvement Found Across Diagnoses With Placebo (Psych Congress Network, June 12, 2023)”
  • González-Safont, Llúcia, et al. “Sleep Problems at Ages 8–9 and ADHD Symptoms at Ages 10–11: Evidence in Three Cohorts from INMA Study.” European Journal of Pediatrics 182, no. 11 (November 2023): 5211-5222. DOI: 10.1007/s00431-023-05145-3.
    • Referenced in “Sleep disorders in childhood found to increase the risk of developing ADHD symptoms (Medical Xpress, June 17, 2024)”
  • Lin, Ping-I, et al. “Pathway from Attention-Deficit/Hyperactivity Disorder to Suicide/Self-Harm.” Psychiatry Research 337 (July 2024): 115936. DOI: 10.1016/j.psychres.2024.115936.
    • Referenced in “Teenagers with ADHD more likely to self-harm, research shows (Medical Xpress, June 18, 2024)”
  • Reed, Claire, et al. “Longitudinal Associations Between Physical Health Conditions in Childhood and Attention-Deficit/Hyperactivity Disorder Symptoms at Age 17 Years.” Journal of the American Academy of Child & Adolescent Psychiatry 63, no. 2 (February 2024): 245-254. DOI: 10.1016/j.jaac.2023.06.016.
    • Referenced in “Childhood Physical Health and ADHD Symptoms (Psychiatric Times, June 14, 2024)”


Attention-Deficit/Hyperactivity Disorder in Children Ages 5–17 Years: United States, 2020–2022

NCHS Data Brief No. 499, March 2024

Data from the National Center for Health Statistics, National Health Interview Survey, 2020–2022, finds that 11.3% of children ages 5-17 in the U.S have ever been diagnosed with ADHD. See the breakdown by age group, race, ethnicity, family income, and insurance coverage at General Prevalence of ADHD.


Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021

Journal of Attention Disorders, March 18, 2024

This study from CDC researchers and CHADD PAB co-chair, Craig Surman, MD, finds that family practice physicians, psychiatrists, and nurse practitioners/psychiatric nurses were the most common providers for adults using employer-sponsored insurance, although the distribution of provider types varied across states. Lower percentages of adults with Medicaid received ADHD care from physicians. Approximately half of adults receiving outpatient ADHD care received ADHD care by telehealth.


ADHD medication and risk of cardiovascular diseases

Commentary by CHADD PAB member, Russell J. Schachar, MD, on Zhang et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases, JAMA Psychiatry, November 22, 2023.


Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults—United States, 2016-2021

Morbidity and Mortality Weekly Report, March 31, 2023
Centers for Disease Control and Prevention


What is already known about this topic?

Prescriptions for stimulants, primarily used to treat attention-deficit/ hyperactivity disorder (ADHD), were increasing for adults before the COVID-19 pandemic. Policies enacted during the pandemic expanded access to prescription stimulants via telehealth.

What is added by this report?

The percentage of adolescent and adult females and adult males receiving prescription stimulant fills increased during 2016-2021, particularly during 2020-2021.

What are the implications for public health practice?

Growing recognition of ADHD in adults and increases in prescription stimulant fills raise questions about current adult ADHD care. Development of clinical recommendations for diagnosing and managing adult ADHD could help guide safe and appropriate stimulant prescribing. Evaluation of policies enacted during the pandemic could identify benefits and harms of those policies.

Go to Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults—United States, 2016-2021 

Recent Webinars For Professionals

Other Resources

Subscribe to our mailing list